nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—sarcoma—acquired immunodeficiency syndrome	0.477	1	CtDrD
Epirubicin—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0647	0.206	CbGbCtD
Epirubicin—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0633	0.201	CbGbCtD
Epirubicin—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0546	0.174	CbGbCtD
Epirubicin—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0479	0.153	CbGbCtD
Epirubicin—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0479	0.153	CbGbCtD
Epirubicin—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0356	0.113	CbGbCtD
Epirubicin—YWHAG—blood plasma—acquired immunodeficiency syndrome	0.00198	0.0398	CbGeAlD
Epirubicin—CHD1—retina—acquired immunodeficiency syndrome	0.00175	0.0352	CbGeAlD
Epirubicin—PLA2G4A—blood plasma—acquired immunodeficiency syndrome	0.00148	0.0297	CbGeAlD
Epirubicin—CHD1—lymphoid tissue—acquired immunodeficiency syndrome	0.00125	0.0251	CbGeAlD
Epirubicin—DHCR7—retina—acquired immunodeficiency syndrome	0.00118	0.0238	CbGeAlD
Epirubicin—CHD1—blood—acquired immunodeficiency syndrome	0.00117	0.0236	CbGeAlD
Epirubicin—CHD1—bone marrow—acquired immunodeficiency syndrome	0.00113	0.0228	CbGeAlD
Epirubicin—CHD1—spinal cord—acquired immunodeficiency syndrome	0.00113	0.0227	CbGeAlD
Epirubicin—CHD1—vagina—acquired immunodeficiency syndrome	0.00109	0.0219	CbGeAlD
Epirubicin—YWHAG—retina—acquired immunodeficiency syndrome	0.00108	0.0218	CbGeAlD
Epirubicin—DHCR7—skin of body—acquired immunodeficiency syndrome	0.00104	0.0209	CbGeAlD
Epirubicin—CHD1—lung—acquired immunodeficiency syndrome	0.00103	0.0207	CbGeAlD
Epirubicin—AURKA—lymphoid tissue—acquired immunodeficiency syndrome	0.001	0.0202	CbGeAlD
Epirubicin—AURKA—digestive system—acquired immunodeficiency syndrome	0.000992	0.0199	CbGeAlD
Epirubicin—CHD1—nervous system—acquired immunodeficiency syndrome	0.000952	0.0191	CbGeAlD
Epirubicin—AURKA—blood—acquired immunodeficiency syndrome	0.000945	0.019	CbGeAlD
Epirubicin—CHD1—central nervous system—acquired immunodeficiency syndrome	0.000916	0.0184	CbGeAlD
Epirubicin—AURKA—bone marrow—acquired immunodeficiency syndrome	0.000914	0.0184	CbGeAlD
Epirubicin—AURKA—vagina—acquired immunodeficiency syndrome	0.000876	0.0176	CbGeAlD
Epirubicin—DHCR7—lymphoid tissue—acquired immunodeficiency syndrome	0.00084	0.0169	CbGeAlD
Epirubicin—DHCR7—digestive system—acquired immunodeficiency syndrome	0.00083	0.0167	CbGeAlD
Epirubicin—AURKA—lung—acquired immunodeficiency syndrome	0.000828	0.0167	CbGeAlD
Epirubicin—DHCR7—blood—acquired immunodeficiency syndrome	0.00079	0.0159	CbGeAlD
Epirubicin—YWHAG—lymphoid tissue—acquired immunodeficiency syndrome	0.000771	0.0155	CbGeAlD
Epirubicin—AURKA—nervous system—acquired immunodeficiency syndrome	0.000767	0.0154	CbGeAlD
Epirubicin—DHCR7—bone marrow—acquired immunodeficiency syndrome	0.000765	0.0154	CbGeAlD
Epirubicin—DHCR7—spinal cord—acquired immunodeficiency syndrome	0.000761	0.0153	CbGeAlD
Epirubicin—YWHAG—digestive system—acquired immunodeficiency syndrome	0.000761	0.0153	CbGeAlD
Epirubicin—AURKA—central nervous system—acquired immunodeficiency syndrome	0.000738	0.0149	CbGeAlD
Epirubicin—DHCR7—vagina—acquired immunodeficiency syndrome	0.000733	0.0147	CbGeAlD
Epirubicin—CHD1—brain—acquired immunodeficiency syndrome	0.000727	0.0146	CbGeAlD
Epirubicin—YWHAG—blood—acquired immunodeficiency syndrome	0.000725	0.0146	CbGeAlD
Epirubicin—CHD1—lymph node—acquired immunodeficiency syndrome	0.000703	0.0141	CbGeAlD
Epirubicin—YWHAG—bone marrow—acquired immunodeficiency syndrome	0.000702	0.0141	CbGeAlD
Epirubicin—YWHAG—spinal cord—acquired immunodeficiency syndrome	0.000699	0.0141	CbGeAlD
Epirubicin—DHCR7—lung—acquired immunodeficiency syndrome	0.000693	0.0139	CbGeAlD
Epirubicin—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.000687	0.0138	CbGeAlD
Epirubicin—YWHAG—vagina—acquired immunodeficiency syndrome	0.000672	0.0135	CbGeAlD
Epirubicin—DHCR7—nervous system—acquired immunodeficiency syndrome	0.000642	0.0129	CbGeAlD
Epirubicin—YWHAG—lung—acquired immunodeficiency syndrome	0.000636	0.0128	CbGeAlD
Epirubicin—DHCR7—central nervous system—acquired immunodeficiency syndrome	0.000618	0.0124	CbGeAlD
Epirubicin—YWHAG—nervous system—acquired immunodeficiency syndrome	0.000589	0.0118	CbGeAlD
Epirubicin—AURKA—brain—acquired immunodeficiency syndrome	0.000586	0.0118	CbGeAlD
Epirubicin—YWHAG—central nervous system—acquired immunodeficiency syndrome	0.000567	0.0114	CbGeAlD
Epirubicin—AURKA—lymph node—acquired immunodeficiency syndrome	0.000566	0.0114	CbGeAlD
Epirubicin—PLA2G4A—blood—acquired immunodeficiency syndrome	0.000541	0.0109	CbGeAlD
Epirubicin—PLA2G4A—bone marrow—acquired immunodeficiency syndrome	0.000523	0.0105	CbGeAlD
Epirubicin—PLA2G4A—spinal cord—acquired immunodeficiency syndrome	0.000521	0.0105	CbGeAlD
Epirubicin—TOP2A—blood—acquired immunodeficiency syndrome	0.000514	0.0103	CbGeAlD
Epirubicin—PLA2G4A—vagina—acquired immunodeficiency syndrome	0.000501	0.0101	CbGeAlD
Epirubicin—AURKA—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.0005	0.196	CbGdCrCtD
Epirubicin—TOP2A—bone marrow—acquired immunodeficiency syndrome	0.000497	0.01	CbGeAlD
Epirubicin—DHCR7—brain—acquired immunodeficiency syndrome	0.00049	0.00986	CbGeAlD
Epirubicin—TOP2A—vagina—acquired immunodeficiency syndrome	0.000476	0.00958	CbGeAlD
Epirubicin—PLA2G4A—lung—acquired immunodeficiency syndrome	0.000474	0.00954	CbGeAlD
Epirubicin—DHCR7—lymph node—acquired immunodeficiency syndrome	0.000474	0.00953	CbGeAlD
Epirubicin—AURKA—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.000457	0.179	CbGdCrCtD
Epirubicin—AURKA—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.000457	0.179	CbGdCrCtD
Epirubicin—TOP2A—lung—acquired immunodeficiency syndrome	0.00045	0.00906	CbGeAlD
Epirubicin—YWHAG—brain—acquired immunodeficiency syndrome	0.00045	0.00905	CbGeAlD
Epirubicin—PLA2G4A—nervous system—acquired immunodeficiency syndrome	0.000439	0.00883	CbGeAlD
Epirubicin—YWHAG—lymph node—acquired immunodeficiency syndrome	0.000435	0.00874	CbGeAlD
Epirubicin—PLA2G4A—central nervous system—acquired immunodeficiency syndrome	0.000423	0.0085	CbGeAlD
Epirubicin—PLA2G4A—brain—acquired immunodeficiency syndrome	0.000336	0.00675	CbGeAlD
Epirubicin—PLA2G4A—lymph node—acquired immunodeficiency syndrome	0.000324	0.00652	CbGeAlD
Epirubicin—ABCC1—blood—acquired immunodeficiency syndrome	0.000309	0.00622	CbGeAlD
Epirubicin—TOP2A—lymph node—acquired immunodeficiency syndrome	0.000308	0.0062	CbGeAlD
Epirubicin—ABCC1—vagina—acquired immunodeficiency syndrome	0.000287	0.00577	CbGeAlD
Epirubicin—ABCC1—lung—acquired immunodeficiency syndrome	0.000271	0.00546	CbGeAlD
Epirubicin—AURKA—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.0881	CbGdCrCtD
Epirubicin—AURKA—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.0809	CbGdCrCtD
Epirubicin—ABCC1—brain—acquired immunodeficiency syndrome	0.000192	0.00386	CbGeAlD
Epirubicin—TOP2A—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.000191	0.0748	CbGdCrCtD
Epirubicin—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000186	0.00373	CbGeAlD
Epirubicin—TOP2A—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.0685	CbGdCrCtD
Epirubicin—TOP2A—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.000175	0.0685	CbGdCrCtD
Epirubicin—TOP2A—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	8.59e-05	0.0337	CbGdCrCtD
Epirubicin—TOP2A—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	7.89e-05	0.0309	CbGdCrCtD
Epirubicin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	4.04e-05	0.000258	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	4.04e-05	0.000258	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	4.03e-05	0.000257	CcSEcCtD
Epirubicin—Pruritus—Abacavir—acquired immunodeficiency syndrome	4.02e-05	0.000257	CcSEcCtD
Epirubicin—Fatigue—Indinavir—acquired immunodeficiency syndrome	4.02e-05	0.000257	CcSEcCtD
Epirubicin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	4.02e-05	0.000257	CcSEcCtD
Epirubicin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	4.02e-05	0.000257	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	4.01e-05	0.000257	CcSEcCtD
Epirubicin—Cough—Saquinavir—acquired immunodeficiency syndrome	4.01e-05	0.000257	CcSEcCtD
Epirubicin—Constipation—Indinavir—acquired immunodeficiency syndrome	3.99e-05	0.000255	CcSEcCtD
Epirubicin—Pain—Indinavir—acquired immunodeficiency syndrome	3.99e-05	0.000255	CcSEcCtD
Epirubicin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	3.98e-05	0.000255	CcSEcCtD
Epirubicin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	3.98e-05	0.000255	CcSEcCtD
Epirubicin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	3.98e-05	0.000255	CcSEcCtD
Epirubicin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	3.98e-05	0.000254	CcSEcCtD
Epirubicin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	3.97e-05	0.000254	CcSEcCtD
Epirubicin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.96e-05	0.000253	CcSEcCtD
Epirubicin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.96e-05	0.000253	CcSEcCtD
Epirubicin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.96e-05	0.000253	CcSEcCtD
Epirubicin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.96e-05	0.000253	CcSEcCtD
Epirubicin—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.95e-05	0.000253	CcSEcCtD
Epirubicin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.95e-05	0.000252	CcSEcCtD
Epirubicin—Nausea—Didanosine—acquired immunodeficiency syndrome	3.95e-05	0.000252	CcSEcCtD
Epirubicin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	3.94e-05	0.000252	CcSEcCtD
Epirubicin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	3.94e-05	0.000252	CcSEcCtD
Epirubicin—Syncope—Lamivudine—acquired immunodeficiency syndrome	3.93e-05	0.000252	CcSEcCtD
Epirubicin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	3.93e-05	0.000251	CcSEcCtD
Epirubicin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	3.93e-05	0.000251	CcSEcCtD
Epirubicin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	3.93e-05	0.000251	CcSEcCtD
Epirubicin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	3.92e-05	0.00025	CcSEcCtD
Epirubicin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	3.91e-05	0.00025	CcSEcCtD
Epirubicin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.91e-05	0.00025	CcSEcCtD
Epirubicin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	3.91e-05	0.00025	CcSEcCtD
Epirubicin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	3.9e-05	0.000249	CcSEcCtD
Epirubicin—Oedema—Ritonavir—acquired immunodeficiency syndrome	3.9e-05	0.000249	CcSEcCtD
Epirubicin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.89e-05	0.000249	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.89e-05	0.000249	CcSEcCtD
Epirubicin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	3.88e-05	0.000248	CcSEcCtD
Epirubicin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.87e-05	0.000247	CcSEcCtD
Epirubicin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	3.85e-05	0.000247	CcSEcCtD
Epirubicin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.84e-05	0.000246	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.84e-05	0.000246	CcSEcCtD
Epirubicin—Shock—Ritonavir—acquired immunodeficiency syndrome	3.83e-05	0.000245	CcSEcCtD
Epirubicin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.83e-05	0.000245	CcSEcCtD
Epirubicin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	3.83e-05	0.000245	CcSEcCtD
Epirubicin—Cough—Lamivudine—acquired immunodeficiency syndrome	3.83e-05	0.000245	CcSEcCtD
Epirubicin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	3.83e-05	0.000245	CcSEcCtD
Epirubicin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.82e-05	0.000244	CcSEcCtD
Epirubicin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.82e-05	0.000244	CcSEcCtD
Epirubicin—Dizziness—Stavudine—acquired immunodeficiency syndrome	3.81e-05	0.000244	CcSEcCtD
Epirubicin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.81e-05	0.000244	CcSEcCtD
Epirubicin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	3.81e-05	0.000244	CcSEcCtD
Epirubicin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	3.8e-05	0.000243	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.8e-05	0.000243	CcSEcCtD
Epirubicin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	3.8e-05	0.000243	CcSEcCtD
Epirubicin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.8e-05	0.000243	CcSEcCtD
Epirubicin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.8e-05	0.000243	CcSEcCtD
Epirubicin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.79e-05	0.000242	CcSEcCtD
Epirubicin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.78e-05	0.000242	CcSEcCtD
Epirubicin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	3.78e-05	0.000242	CcSEcCtD
Epirubicin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	3.77e-05	0.000241	CcSEcCtD
Epirubicin—Constipation—Efavirenz—acquired immunodeficiency syndrome	3.77e-05	0.000241	CcSEcCtD
Epirubicin—Pain—Efavirenz—acquired immunodeficiency syndrome	3.77e-05	0.000241	CcSEcCtD
Epirubicin—Rash—Nevirapine—acquired immunodeficiency syndrome	3.77e-05	0.000241	CcSEcCtD
Epirubicin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.76e-05	0.000241	CcSEcCtD
Epirubicin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	3.76e-05	0.00024	CcSEcCtD
Epirubicin—Dizziness—Abacavir—acquired immunodeficiency syndrome	3.76e-05	0.00024	CcSEcCtD
Epirubicin—Oedema—Saquinavir—acquired immunodeficiency syndrome	3.75e-05	0.00024	CcSEcCtD
Epirubicin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	3.75e-05	0.00024	CcSEcCtD
Epirubicin—Headache—Nevirapine—acquired immunodeficiency syndrome	3.74e-05	0.000239	CcSEcCtD
Epirubicin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.73e-05	0.000239	CcSEcCtD
Epirubicin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	3.73e-05	0.000239	CcSEcCtD
Epirubicin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.73e-05	0.000239	CcSEcCtD
Epirubicin—Infection—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000238	CcSEcCtD
Epirubicin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	3.72e-05	0.000238	CcSEcCtD
Epirubicin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.72e-05	0.000238	CcSEcCtD
Epirubicin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	3.71e-05	0.000237	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000237	CcSEcCtD
Epirubicin—Urticaria—Indinavir—acquired immunodeficiency syndrome	3.7e-05	0.000237	CcSEcCtD
Epirubicin—Shock—Saquinavir—acquired immunodeficiency syndrome	3.69e-05	0.000236	CcSEcCtD
Epirubicin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.69e-05	0.000236	CcSEcCtD
Epirubicin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.69e-05	0.000236	CcSEcCtD
Epirubicin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.69e-05	0.000236	CcSEcCtD
Epirubicin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.68e-05	0.000235	CcSEcCtD
Epirubicin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.68e-05	0.000235	CcSEcCtD
Epirubicin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.67e-05	0.000235	CcSEcCtD
Epirubicin—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.67e-05	0.000235	CcSEcCtD
Epirubicin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.66e-05	0.000234	CcSEcCtD
Epirubicin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	3.65e-05	0.000234	CcSEcCtD
Epirubicin—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.65e-05	0.000233	CcSEcCtD
Epirubicin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.64e-05	0.000233	CcSEcCtD
Epirubicin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3.64e-05	0.000233	CcSEcCtD
Epirubicin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	3.64e-05	0.000233	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3.64e-05	0.000233	CcSEcCtD
Epirubicin—Rash—Stavudine—acquired immunodeficiency syndrome	3.64e-05	0.000233	CcSEcCtD
Epirubicin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3.63e-05	0.000232	CcSEcCtD
Epirubicin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.63e-05	0.000232	CcSEcCtD
Epirubicin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	3.63e-05	0.000232	CcSEcCtD
Epirubicin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	3.63e-05	0.000232	CcSEcCtD
Epirubicin—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.62e-05	0.000232	CcSEcCtD
Epirubicin—Headache—Stavudine—acquired immunodeficiency syndrome	3.61e-05	0.000231	CcSEcCtD
Epirubicin—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.61e-05	0.000231	CcSEcCtD
Epirubicin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	3.61e-05	0.000231	CcSEcCtD
Epirubicin—Pain—Delavirdine—acquired immunodeficiency syndrome	3.6e-05	0.000231	CcSEcCtD
Epirubicin—Constipation—Delavirdine—acquired immunodeficiency syndrome	3.6e-05	0.000231	CcSEcCtD
Epirubicin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.6e-05	0.00023	CcSEcCtD
Epirubicin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.6e-05	0.00023	CcSEcCtD
Epirubicin—Rash—Abacavir—acquired immunodeficiency syndrome	3.58e-05	0.000229	CcSEcCtD
Epirubicin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.58e-05	0.000229	CcSEcCtD
Epirubicin—Oedema—Lamivudine—acquired immunodeficiency syndrome	3.58e-05	0.000229	CcSEcCtD
Epirubicin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	3.58e-05	0.000229	CcSEcCtD
Epirubicin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.58e-05	0.000229	CcSEcCtD
Epirubicin—Headache—Abacavir—acquired immunodeficiency syndrome	3.56e-05	0.000228	CcSEcCtD
Epirubicin—Infection—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.000227	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.55e-05	0.000227	CcSEcCtD
Epirubicin—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.55e-05	0.000227	CcSEcCtD
Epirubicin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.55e-05	0.000227	CcSEcCtD
Epirubicin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	3.53e-05	0.000225	CcSEcCtD
Epirubicin—Shock—Lamivudine—acquired immunodeficiency syndrome	3.52e-05	0.000225	CcSEcCtD
Epirubicin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	3.51e-05	0.000224	CcSEcCtD
Epirubicin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	3.51e-05	0.000224	CcSEcCtD
Epirubicin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	3.5e-05	0.000224	CcSEcCtD
Epirubicin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	3.5e-05	0.000224	CcSEcCtD
Epirubicin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	3.5e-05	0.000224	CcSEcCtD
Epirubicin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	3.48e-05	0.000223	CcSEcCtD
Epirubicin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	3.48e-05	0.000223	CcSEcCtD
Epirubicin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	3.48e-05	0.000222	CcSEcCtD
Epirubicin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	3.48e-05	0.000222	CcSEcCtD
Epirubicin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	3.47e-05	0.000222	CcSEcCtD
Epirubicin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	3.47e-05	0.000222	CcSEcCtD
Epirubicin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	3.46e-05	0.000221	CcSEcCtD
Epirubicin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	3.45e-05	0.00022	CcSEcCtD
Epirubicin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	3.44e-05	0.00022	CcSEcCtD
Epirubicin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	3.44e-05	0.00022	CcSEcCtD
Epirubicin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	3.43e-05	0.000219	CcSEcCtD
Epirubicin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	3.43e-05	0.000219	CcSEcCtD
Epirubicin—Nausea—Stavudine—acquired immunodeficiency syndrome	3.43e-05	0.000219	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	3.42e-05	0.000219	CcSEcCtD
Epirubicin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	3.41e-05	0.000218	CcSEcCtD
Epirubicin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	3.39e-05	0.000217	CcSEcCtD
Epirubicin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	3.39e-05	0.000217	CcSEcCtD
Epirubicin—Nausea—Abacavir—acquired immunodeficiency syndrome	3.38e-05	0.000216	CcSEcCtD
Epirubicin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	3.37e-05	0.000215	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	3.37e-05	0.000215	CcSEcCtD
Epirubicin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	3.36e-05	0.000215	CcSEcCtD
Epirubicin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	3.35e-05	0.000214	CcSEcCtD
Epirubicin—Asthenia—Indinavir—acquired immunodeficiency syndrome	3.35e-05	0.000214	CcSEcCtD
Epirubicin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	3.34e-05	0.000214	CcSEcCtD
Epirubicin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	3.34e-05	0.000214	CcSEcCtD
Epirubicin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	3.34e-05	0.000213	CcSEcCtD
Epirubicin—Pain—Ritonavir—acquired immunodeficiency syndrome	3.33e-05	0.000213	CcSEcCtD
Epirubicin—Constipation—Ritonavir—acquired immunodeficiency syndrome	3.33e-05	0.000213	CcSEcCtD
Epirubicin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	3.33e-05	0.000213	CcSEcCtD
Epirubicin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	3.33e-05	0.000213	CcSEcCtD
Epirubicin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	3.32e-05	0.000212	CcSEcCtD
Epirubicin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	3.3e-05	0.000211	CcSEcCtD
Epirubicin—Pruritus—Indinavir—acquired immunodeficiency syndrome	3.3e-05	0.000211	CcSEcCtD
Epirubicin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	3.26e-05	0.000209	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	3.26e-05	0.000209	CcSEcCtD
Epirubicin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	3.25e-05	0.000208	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	3.24e-05	0.000207	CcSEcCtD
Epirubicin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.000207	CcSEcCtD
Epirubicin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	3.23e-05	0.000207	CcSEcCtD
Epirubicin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	3.21e-05	0.000206	CcSEcCtD
Epirubicin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	3.21e-05	0.000205	CcSEcCtD
Epirubicin—Pain—Saquinavir—acquired immunodeficiency syndrome	3.21e-05	0.000205	CcSEcCtD
Epirubicin—Constipation—Saquinavir—acquired immunodeficiency syndrome	3.21e-05	0.000205	CcSEcCtD
Epirubicin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	3.19e-05	0.000204	CcSEcCtD
Epirubicin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	3.19e-05	0.000204	CcSEcCtD
Epirubicin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	3.19e-05	0.000204	CcSEcCtD
Epirubicin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	3.19e-05	0.000204	CcSEcCtD
Epirubicin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	3.18e-05	0.000203	CcSEcCtD
Epirubicin—Rash—Zidovudine—acquired immunodeficiency syndrome	3.16e-05	0.000202	CcSEcCtD
Epirubicin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	3.16e-05	0.000202	CcSEcCtD
Epirubicin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	3.16e-05	0.000202	CcSEcCtD
Epirubicin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	3.15e-05	0.000201	CcSEcCtD
Epirubicin—Headache—Zidovudine—acquired immunodeficiency syndrome	3.14e-05	0.000201	CcSEcCtD
Epirubicin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	3.12e-05	0.000199	CcSEcCtD
Epirubicin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	3.11e-05	0.000199	CcSEcCtD
Epirubicin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	3.11e-05	0.000199	CcSEcCtD
Epirubicin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	3.1e-05	0.000198	CcSEcCtD
Epirubicin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	3.09e-05	0.000198	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	3.09e-05	0.000198	CcSEcCtD
Epirubicin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	3.09e-05	0.000197	CcSEcCtD
Epirubicin—Dizziness—Indinavir—acquired immunodeficiency syndrome	3.08e-05	0.000197	CcSEcCtD
Epirubicin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	3.08e-05	0.000197	CcSEcCtD
Epirubicin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	3.08e-05	0.000197	CcSEcCtD
Epirubicin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	3.07e-05	0.000196	CcSEcCtD
Epirubicin—Constipation—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000196	CcSEcCtD
Epirubicin—Pain—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000196	CcSEcCtD
Epirubicin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	3.02e-05	0.000193	CcSEcCtD
Epirubicin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	3.01e-05	0.000193	CcSEcCtD
Epirubicin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.98e-05	0.000191	CcSEcCtD
Epirubicin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	2.98e-05	0.000191	CcSEcCtD
Epirubicin—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.98e-05	0.00019	CcSEcCtD
Epirubicin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.97e-05	0.00019	CcSEcCtD
Epirubicin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.97e-05	0.00019	CcSEcCtD
Epirubicin—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.96e-05	0.00019	CcSEcCtD
Epirubicin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.95e-05	0.000189	CcSEcCtD
Epirubicin—Rash—Indinavir—acquired immunodeficiency syndrome	2.94e-05	0.000188	CcSEcCtD
Epirubicin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.94e-05	0.000188	CcSEcCtD
Epirubicin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.93e-05	0.000187	CcSEcCtD
Epirubicin—Headache—Indinavir—acquired immunodeficiency syndrome	2.92e-05	0.000187	CcSEcCtD
Epirubicin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.91e-05	0.000186	CcSEcCtD
Epirubicin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.88e-05	0.000184	CcSEcCtD
Epirubicin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.87e-05	0.000184	CcSEcCtD
Epirubicin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	2.84e-05	0.000182	CcSEcCtD
Epirubicin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.83e-05	0.000181	CcSEcCtD
Epirubicin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.83e-05	0.000181	CcSEcCtD
Epirubicin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.8e-05	0.000179	CcSEcCtD
Epirubicin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.8e-05	0.000179	CcSEcCtD
Epirubicin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.79e-05	0.000178	CcSEcCtD
Epirubicin—Rash—Efavirenz—acquired immunodeficiency syndrome	2.78e-05	0.000178	CcSEcCtD
Epirubicin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.78e-05	0.000177	CcSEcCtD
Epirubicin—Nausea—Indinavir—acquired immunodeficiency syndrome	2.77e-05	0.000177	CcSEcCtD
Epirubicin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.76e-05	0.000177	CcSEcCtD
Epirubicin—Headache—Efavirenz—acquired immunodeficiency syndrome	2.76e-05	0.000177	CcSEcCtD
Epirubicin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.76e-05	0.000176	CcSEcCtD
Epirubicin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.69e-05	0.000172	CcSEcCtD
Epirubicin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.68e-05	0.000171	CcSEcCtD
Epirubicin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.67e-05	0.000171	CcSEcCtD
Epirubicin—Rash—Delavirdine—acquired immunodeficiency syndrome	2.66e-05	0.00017	CcSEcCtD
Epirubicin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.66e-05	0.00017	CcSEcCtD
Epirubicin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.65e-05	0.00017	CcSEcCtD
Epirubicin—Headache—Delavirdine—acquired immunodeficiency syndrome	2.64e-05	0.000169	CcSEcCtD
Epirubicin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.64e-05	0.000169	CcSEcCtD
Epirubicin—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.62e-05	0.000167	CcSEcCtD
Epirubicin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.58e-05	0.000165	CcSEcCtD
Epirubicin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.57e-05	0.000164	CcSEcCtD
Epirubicin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.57e-05	0.000164	CcSEcCtD
Epirubicin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.53e-05	0.000162	CcSEcCtD
Epirubicin—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.5e-05	0.00016	CcSEcCtD
Epirubicin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.48e-05	0.000159	CcSEcCtD
Epirubicin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.48e-05	0.000159	CcSEcCtD
Epirubicin—Rash—Ritonavir—acquired immunodeficiency syndrome	2.46e-05	0.000157	CcSEcCtD
Epirubicin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.46e-05	0.000157	CcSEcCtD
Epirubicin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.45e-05	0.000157	CcSEcCtD
Epirubicin—Headache—Ritonavir—acquired immunodeficiency syndrome	2.44e-05	0.000156	CcSEcCtD
Epirubicin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.39e-05	0.000153	CcSEcCtD
Epirubicin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	2.37e-05	0.000151	CcSEcCtD
Epirubicin—Rash—Saquinavir—acquired immunodeficiency syndrome	2.37e-05	0.000151	CcSEcCtD
Epirubicin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.36e-05	0.000151	CcSEcCtD
Epirubicin—Headache—Saquinavir—acquired immunodeficiency syndrome	2.35e-05	0.00015	CcSEcCtD
Epirubicin—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.32e-05	0.000148	CcSEcCtD
Epirubicin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.28e-05	0.000146	CcSEcCtD
Epirubicin—Rash—Lamivudine—acquired immunodeficiency syndrome	2.26e-05	0.000144	CcSEcCtD
Epirubicin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.25e-05	0.000144	CcSEcCtD
Epirubicin—Headache—Lamivudine—acquired immunodeficiency syndrome	2.24e-05	0.000143	CcSEcCtD
Epirubicin—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.23e-05	0.000143	CcSEcCtD
Epirubicin—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.13e-05	0.000136	CcSEcCtD
